BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26356565)

  • 1. Quelling an innate response to dsRNA.
    Ogden KM; Prasad BV
    Oncotarget; 2015 Oct; 6(30):28535-6. PubMed ID: 26356565
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of antiviral action of interferon.
    Baglioni C; Nilsen TW
    Interferon; 1983; 5():23-42. PubMed ID: 6202642
    [No Abstract]   [Full Text] [Related]  

  • 3. The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors.
    Wood ER; Bledsoe R; Chai J; Daka P; Deng H; Ding Y; Harris-Gurley S; Kryn LH; Nartey E; Nichols J; Nolte RT; Prabhu N; Rise C; Sheahan T; Shotwell JB; Smith D; Tai V; Taylor JD; Tomberlin G; Wang L; Wisely B; You S; Xia B; Dickson H
    J Biol Chem; 2015 Aug; 290(32):19681-96. PubMed ID: 26055709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Processing of double-stranded RNA in mammalian cells: a direct antiviral role?
    Gantier MP
    J Interferon Cytokine Res; 2014 Jun; 34(6):469-77. PubMed ID: 24905204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OASL-a new player in controlling antiviral innate immunity.
    Zhu J; Ghosh A; Sarkar SN
    Curr Opin Virol; 2015 Jun; 12():15-9. PubMed ID: 25676874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities.
    Kristiansen H; Gad HH; Eskildsen-Larsen S; Despres P; Hartmann R
    J Interferon Cytokine Res; 2011 Jan; 31(1):41-7. PubMed ID: 21142819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon action: binding of viral RNA to the 40-kilodalton 2'-5'-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus.
    Gribaudo G; Lembo D; Cavallo G; Landolfo S; Lengyel P
    J Virol; 1991 Apr; 65(4):1748-57. PubMed ID: 1705989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.
    Sánchez-Tacuba L; Rojas M; Arias CF; López S
    J Virol; 2015 Dec; 89(23):12145-53. PubMed ID: 26401041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity.
    Kristiansen H; Scherer CA; McVean M; Iadonato SP; Vends S; Thavachelvam K; Steffensen TB; Horan KA; Kuri T; Weber F; Paludan SR; Hartmann R
    J Virol; 2010 Nov; 84(22):11898-904. PubMed ID: 20844035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the role of RNase L in innate immunity.
    Chakrabarti A; Jha BK; Silverman RH
    J Interferon Cytokine Res; 2011 Jan; 31(1):49-57. PubMed ID: 21190483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection.
    Musumeci G; Castrogiovanni P; Barbagallo I; Tibullo D; Sanfilippo C; Nunnari G; Pellicanò GF; Pavone P; Caltabiano R; Di Marco R; Imbesi R; Di Rosa M
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the oligoadenylate synthetases-like protein and does it have therapeutic potential for influenza?
    Alcorn JF; Sarkar SN
    Expert Rev Respir Med; 2015 Feb; 9(1):1-3. PubMed ID: 25544107
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Yao YL; Yu D; Xu L; Gu T; Li Y; Zheng X; Bi R; Yao YG
    J Immunol; 2020 Dec; 205(12):3419-3428. PubMed ID: 33188074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [OAS genes and susceptibility to West Nile virus].
    Guénet JL; Després P
    Med Sci (Paris); 2003 Jan; 19(1):9-12. PubMed ID: 12836183
    [No Abstract]   [Full Text] [Related]  

  • 15. 2-5A-antisense chimeras: inhibitors of respiratory syncytial virus infection.
    Torrence PF
    Curr Opin Mol Ther; 1999 Jun; 1(3):307-15. PubMed ID: 11713795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A.
    Silverman RH; Weiss SR
    J Interferon Cytokine Res; 2014 Jun; 34(6):455-63. PubMed ID: 24905202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional evolution of the OAS1 viral sensor: Insights from old world primates.
    Fish I; Boissinot S
    Infect Genet Evol; 2016 Oct; 44():341-350. PubMed ID: 27393659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All About the RNA: Interferon-Stimulated Genes That Interfere With Viral RNA Processes.
    Yang E; Li MMH
    Front Immunol; 2020; 11():605024. PubMed ID: 33362792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologous 2',5'-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity.
    Zhang R; Jha BK; Ogden KM; Dong B; Zhao L; Elliott R; Patton JT; Silverman RH; Weiss SR
    Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13114-9. PubMed ID: 23878220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.
    Carey CM; Govande AA; Cooper JM; Hartley MK; Kranzusch PJ; Elde NC
    Cell Host Microbe; 2019 Feb; 25(2):336-343.e4. PubMed ID: 30713099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.